Status:
RECRUITING
Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
University Hospital, Rouen
Conditions:
Neuroblastoma
Ewing Sarcoma
Eligibility:
All Genders
2-45 years
Brief Summary
In prepubertal patients, cryopreservation of ovarian or testicular tissue is currently the only available method for fertility preservation prior to gonadotoxic cancer treatments. However, this approa...
Detailed Description
Ovarian and testicular cryopreservation is the only option to preserve the fertility of children diagnosed with cancer. Cancer treatments such as chemotherapy and radiotherapy can lead to gonadal toxi...
Eligibility Criteria
Inclusion
- Women of any age diagnosed with a benign cyst requiring laparoscopy may be included.
- Men of any age diagnosed with a non-obstructive azoospermia may be included.
- Prepubertal girls and boys diagnosed with neuroblastoma or Ewing sarcoma during infancy may be included.
- Capable of providing written informed consent to participate in the research study
- Affiliated with a social welfare service.
- For prepubertal patients, written informed consent to participate in the research study must be provided by their parents or legal guardians.
Exclusion
- None
Key Trial Info
Start Date :
February 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT07141862
Start Date
February 1 2025
End Date
December 31 2027
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital
Clermont-Ferrand, Auvergne, France, 63000